175,000 Bottles of Blood Pressure Drugs Recalled Over Carcinogens, FDA Says

The recall of prazosin hydrochloride, sometimes used to treat PTSD, is ongoing.

The U.S. Food and Drug Administration campus in Silver Spring, Md., on Oct. 14, 2015. Andrew Harnik/AP Photo

A drug manufacturer has recalled multiple lots of a type of blood pressure medication due to carcinogenic impurities, according to the Food and Drug Administration (FDA).

Appco Pharma LLC is recalling 175,061 bottles of 1-milligram, 2-milligram, and 5-milligram dosages of prazosin hydrochloride capsules, the FDA said in a March 31 report, providing a list of expiration dates and lots for the drugs.